Literature DB >> 17712679

Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.

Kerstin Rosenquist1, Johan Wennerberg, Karin Annertz, Elsy-Britt Schildt, Bengt Göran Hansson, Anna Bladström, Gunilla Andersson.   

Abstract

CONCLUSIONS: The results confirm that tumour stage influences the risk of recurrence/second primary tumour (SPT). High-risk human papillomavirus (HPV)-infected patients have a significantly higher risk of recurrence/SPT compared with high-risk HPV-negative patients. High alcohol consumption was associated with a higher risk of recurrence/SPT. In this study, the competing risk of death in intercurrent disease (DICD) was given special consideration.
OBJECTIVES: The aim of the present study was to evaluate whether any of the factors which were found to increase the risk of oral and oropharyngeal squamous cell carcinoma (OOSCC) in previous analyses (smoking tobacco, alcohol, high-risk HPV infection, oral hygiene, missing teeth and dentures) have an influence on recurrence or the occurrence of a new SPT of OOSCC within the first 3 years following diagnosis. PATIENTS AND METHODS: One hundred and twenty-eight consecutive cases with planned curative treatment, who were part of a population-based case-control study carried out in southern Sweden between September 2000 and January 2004, were included. Only patients for whom the intention was curative treatment were eligible. The cases were followed to the first event of recurrence/SPT, death, loss to follow-up, 30 June 2005 or a maximum of 3 years. Time to the first event of recurrence/SPT was analysed by cumulative incidence, where DICD was a competing risk. Regression was performed on cause-specific hazard rates.
RESULTS: After a median follow-up time of 22 months (range 0-36 months), 30 recurrences, 2 SPT, 12 lost to follow-up and 21 deaths before recurrence or SPT were observed. Tumour stage was associated with both a higher risk of recurrence/SPT and of DICD. In univariate analysis, patients with tonsillar carcinoma had a significantly higher risk of recurrence/SPT than patients with carcinoma at other sites, but there was no difference according to site in multivariate analyses. High alcohol consumption was associated with a higher risk of recurrence/SPT, but not of DICD. There was no increased risk of recurrence/SPT related to smoking, but there was an association between smoking and DICD. High-risk HPV-positive cases had a higher risk of recurrence/SPT, but a lower risk of DICD compared with high-risk HPV-negative cases. This seemingly higher risk should be interpreted by taking the competing risk of DICD into account.

Entities:  

Mesh:

Year:  2007        PMID: 17712679     DOI: 10.1080/00016480601110162

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

1.  MAGE-A antigens in lesions of the oral mucosa.

Authors:  Eva Krauss; Stephan Rauthe; Stefan Gattenlöhner; Tobias Reuther; Michael Kochel; Ulrike Kriegebaum; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2010-02-20       Impact factor: 3.573

2.  Current-Smoking-Related COPD or COPD With Acute Exacerbation is Associated With Poorer Survival Following Oral Cavity Squamous Cell Carcinoma Surgery.

Authors:  Jiaqiang Zhang; Wei-Chun Lin; Kuo-Chin Chiu; Szu-Yuan Wu
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

Review 3.  Immune suppression in head and neck cancers: a review.

Authors:  Anaëlle Duray; Stéphanie Demoulin; Pascale Hubert; Philippe Delvenne; Sven Saussez
Journal:  Clin Dev Immunol       Date:  2011-03-10

4.  Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma.

Authors:  Perle Ernoux-Neufcoeur; Mohammad Arafa; Christine Decaestecker; Anaëlle Duray; Myriam Remmelink; Xavier Leroy; Michael Herfs; Joan Somja; Christophe E Depuydt; Philippe Delvenne; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-08       Impact factor: 4.553

5.  Proteomic study of HPV-positive head and neck cancers: preliminary results.

Authors:  Géraldine Descamps; Ruddy Wattiez; Sven Saussez
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

6.  Tobacco and alcohol cessation or reduction interventions in people with oral dysplasia and head and neck cancer: systematic review protocol.

Authors:  Ellie Shingler; Luke A Robles; Rachel Perry; Chris Penfold; Andy Ness; Steve Thomas; J Athene Lane; Richard M Martin
Journal:  Syst Rev       Date:  2017-08-10

7.  Impact of HPV infection on oral squamous cell carcinoma.

Authors:  Carolin Götz; Enken Drecoll; Melanie Straub; Oliver Bissinger; Klaus-Dietrich Wolff; Andreas Kolk
Journal:  Oncotarget       Date:  2016-11-22

8.  Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Authors:  Géraldine Descamps; Yasemin Karaca; Jérôme R Lechien; Nadège Kindt; Christine Decaestecker; Myriam Remmelink; Denis Larsimont; Guy Andry; Samantha Hassid; Alexandra Rodriguez; Mohammad Khalife; Fabrice Journe; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-01       Impact factor: 4.553

9.  Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium.

Authors:  Emanuele Leoncini; Vladimir Vukovic; Gabriella Cadoni; Luca Giraldi; Roberta Pastorino; Dario Arzani; Livia Petrelli; Victor Wünsch-Filho; Tatiana Natasha Toporcov; Raquel Ayub Moyses; Keitaro Matsuo; Cristina Bosetti; Carlo La Vecchia; Diego Serraino; Lorenzo Simonato; Franco Merletti; Paolo Boffetta; Mia Hashibe; Yuan-Chin Amy Lee; Stefania Boccia
Journal:  Eur J Epidemiol       Date:  2018-05-19       Impact factor: 8.082

10.  Systematic review evaluating randomized controlled trials of smoking and alcohol cessation interventions in people with head and neck cancer and oral dysplasia.

Authors:  Ellie Shingler; Luke A Robles; Rachel Perry; Chris Penfold; Andy R Ness; Steve Thomas; J Athene Lane; Richard M Martin
Journal:  Head Neck       Date:  2018-03-30       Impact factor: 3.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.